R Squared Ltd Acquires Shares of 1,100 The Cooper Companies, Inc. (NASDAQ:COO)

R Squared Ltd bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 1,100 shares of the medical device company’s stock, valued at approximately $101,000.

Several other hedge funds and other institutional investors have also modified their holdings of COO. State Street Corp raised its holdings in Cooper Companies by 1.2% in the 3rd quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock valued at $947,897,000 after acquiring an additional 104,521 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after purchasing an additional 573,908 shares during the period. Geode Capital Management LLC lifted its holdings in Cooper Companies by 1.0% during the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock worth $527,476,000 after purchasing an additional 48,559 shares during the last quarter. Victory Capital Management Inc. boosted its stake in Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after purchasing an additional 737,726 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Cooper Companies by 11.9% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after buying an additional 194,118 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

NASDAQ:COO opened at $98.10 on Friday. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock’s 50-day simple moving average is $95.88 and its 200 day simple moving average is $99.53. The firm has a market capitalization of $19.58 billion, a PE ratio of 50.31, a price-to-earnings-growth ratio of 2.41 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm’s revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.87 EPS. On average, analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on COO shares. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Citigroup lowered their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Wells Fargo & Company increased their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Finally, Morgan Stanley lowered their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.